Literature DB >> 10718491

Reproductive factors in hereditary breast cancer.

H C Jernström1, O T Johannsson, N Loman, A Borg, H Olsson.   

Abstract

BACKGROUND: An early age at menarche, a short menstrual cycle length, and a high age at first full term pregnancy or nulliparity are known risk factors for breast cancer. These risk factors have previously been reported to differ between breast cancer patients with and without a family history of breast cancer and also between breast cancer patients and controls.
METHODS: Self-administered questionnaires were filled out by 95 women belonging to 24 families with known BRCA1 mutations, 16 women belonging to nine families with known BRCA2 mutations, and 95 women belonging to 65 families with hereditary breast cancer where no BRCA1 or BRCA2 mutations could be detected. Thirty-nine women were BRCA1 mutation carriers and 56 women were BRCA1 negative, 11 women were BRCA2 carriers and five BRCA2 negative. All women were born between 1905 and 1979.
RESULTS: Age at menarche, physiological menstrual cycle length at age 30 or at current age in younger women (when not using oral contraceptives), age at first full term pregnancy, and nulliparity did not significantly differ between BRCA1 mutation carriers and BRCA1 negative women. Too few women were BRCA2 negative to serve as a control group. BRCA2 mutation carriers were therefore compared with BRCA1 negative and BRCA2 negative women. None of the above reproductive factors did significantly differ between BRCA2 mutation carriers and from BRCA1 and BRCA2 families. Women from non-BRCA1/BRCA2 hereditary breast cancer families had a higher age at menarche, but this was no longer significant after adjustment for other factors in a multivariate model.
CONCLUSION: Our results suggest that reproductive risk factors of breast cancer are not related to BRCA1 or BRCA2 carrier status. There was also no indication that these factors differ in carriers of unknown susceptibility genes compared with non-carriers from BRCA1 and BRCA2 families.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10718491     DOI: 10.1023/a:1006375123262

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  6 in total

Review 1.  Hormone-induced protection against breast cancer.

Authors:  Lakshmi Sivaraman; Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

2.  Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County.

Authors:  Sara Margolin; Hemming Johansson; Lars Erik Rutqvist; Annika Lindblom; Tommy Fornander
Journal:  Fam Cancer       Date:  2006-07-01       Impact factor: 2.375

3.  Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.

Authors:  Jenny N Poynter; Bryan Langholz; Joan Largent; Lene Mellemkjaer; Leslie Bernstein; Kathleen E Malone; Charles F Lynch; Ake Borg; Patrick Concannon; Sharon N Teraoka; Shanyan Xue; Anh T Diep; Therese Törngren; Colin B Begg; Marinela Capanu; Robert W Haile; Jonine L Bernstein
Journal:  Cancer Causes Control       Date:  2010-02-04       Impact factor: 2.506

4.  Relationship between family history of breast cancer and clinicopathological features in Moroccan patients.

Authors:  Amal Tazzite; Hassan Jouhadi; Kamal Saiss; Abdellatif Benider; Sellama Nadifi
Journal:  Ethiop J Health Sci       Date:  2013-07

5.  Successful pregnancy after breast cancer therapy: dream or reality?

Authors:  Konstantinos Kontzoglou; Michael Stamatakos; Sofia Tsaknaki; Helen Goga; Alkiviades Kostakis; Michael Safioleas
Journal:  Int Semin Surg Oncol       Date:  2009-03-02

6.  BRCA2 mutation carriers, reproductive factors and breast cancer risk.

Authors:  Laufey Tryggvadottir; Elinborg J Olafsdottir; Sigfridur Gudlaugsdottir; Steinunn Thorlacius; Jon G Jonasson; Hrafn Tulinius; Jorunn E Eyfjord
Journal:  Breast Cancer Res       Date:  2003-06-24       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.